A method for automated molecular optimization applied to Ames mutagenicity data.

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Toxicology

Background:

• Quantitative structure-activity relationship (QSAR) models are crucial for predicting compound properties.
• Mutagenicity is a significant safety concern in drug development, necessitating methods to mitigate this liability.
• Identifying and modifying structural features responsible for toxicity is a key challenge in medicinal chemistry.

Purpose of the Study:

• To develop and validate a computational method for optimizing compounds by reducing mutagenicity.
• To identify and replace mutagenic substructures within query compounds using QSAR interpretation.
• To generate novel, non-mutagenic compounds with potentially lower safety liabilities.

Main Methods:

• Application of a novel method based on QSAR model interpretation to identify mutagenic substructures.
• Deterministic generation of replacement substructures to create new, non-mutagenic compound analogs.
• Evaluation of the generated compounds for reduced mutagenicity liability.

Main Results:

• The method successfully identified and replaced key substructures contributing to mutagenicity predictions.
• A library of new, non-mutagenic compounds was generated, some of which were previously known but unrecognized by the method.
• Demonstrated the capability to substitute toxic substructures and reduce mutagenicity liability for specific endpoints.

Conclusions:

• The described method offers a powerful approach to designing safer chemical entities by proactively addressing mutagenicity.
• This computational strategy can complement or potentially replace traditional database searches for avoiding safety issues in compound design.
• The approach facilitates the creation of compound libraries with inherently lower toxicological liabilities.